Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660.
Article CAS PubMed Google Scholar
Denlinger CS, Carlson RW, Are M, et al. Survivorship: introduction and definition. Clinical practice guidelines in oncology. J Natl Comprehen Cancer Netw: JNCCN. 2014;12:34–45. https://doi.org/10.6004/jnccn.2014.0005.
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet (London, England). 2018;391:1023–75. https://doi.org/10.1016/S0140-6736(17)33326-3.
Article PubMed PubMed Central Google Scholar
The Cancer Atlas. Cancer Surv.; 2023. https://canceratlas.cancer.org/the-burden/cancer-survivorship/. Accessed 15 Mar 2023.
Harrison JD, Young JM, Price MA, Butow PN, Solomon MJ. What are the unmet supportive care needs of people with cancer? A systematic review. Support Care Cancer. 2009;17:1117–28. https://doi.org/10.1007/s00520-009-0615-5.
Luigjes-Huizer YL, Tauber NM, Humphris G, et al. What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis. Psycho Oncol. 2022;31:879–92. https://doi.org/10.1002/pon.5921.
Lebel S, Ozakinci G, Humphris G, et al. From normal response to clinical problem: definition and clinical features of fear of cancer recurrence. Support Care Cancer. 2016;24:3265–8. https://doi.org/10.1007/s00520-016-3272-5.
Götze H, Taubenheim S, Dietz A, Lordick F, Mehnert-Theuerkauf A. Fear of cancer recurrence across the survivorship trajectory: results from a survey of adult long-term cancer survivors. Psycho Oncol. 2019;28:2033–41. https://doi.org/10.1002/pon.5188.
Mutsaers B, Jones G, Rutkowski N, et al. When fear of cancer recurrence becomes a clinical issue: a qualitative analysis of features associated with clinical fear of cancer recurrence. Support Care Cancer. 2016;24:4207–18. https://doi.org/10.1007/s00520-016-3248-5.
Nguena Nguefack HL, Pagé MG, Katz J, et al. Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches. Clin Epidemiol. 2020;12:1205–22. https://doi.org/10.2147/CLEP.S265287.
Article PubMed PubMed Central Google Scholar
Berlin KS, Parra GR, Williams NA. An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models. J Pediatr Psychol. 2014;39:188–203. https://doi.org/10.1093/jpepsy/jst085.
Ram N, Grimm KJ. Growth mixture modeling: a method for identifying differences in longitudinal change among unobserved groups. Int J Behav Dev. 2009;33:565–76. https://doi.org/10.1177/0165025409343765.
Article PubMed PubMed Central Google Scholar
Yang Y, Qi H, Li W, et al. Predictors and trajectories of fear of cancer recurrence in Chinese breast cancer patients. J Psychosom Res. 2023;166:111177. https://doi.org/10.1016/j.jpsychores.2023.111177.
Deuning-Smit E, Custers J, Miroševič Š, et al. Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: course, trajectories, and associated factors. Head Neck. 2022;44:914–25. https://doi.org/10.1002/hed.26985.
Article PubMed PubMed Central Google Scholar
Manne SL, Myers-Virtue S, Kissane D, et al. Group-based trajectory modeling of fear of disease recurrence among women recently diagnosed with gynecological cancers. Psycho Oncol. 2017;26:1799–809. https://doi.org/10.1002/pon.4223.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed). 2021;372:n71. https://doi.org/10.1136/bmj.n71.
Article PubMed PubMed Central Google Scholar
JBI Critical Appraisal Tools; 2024. https://jbi.global/critical-appraisal-tools. Accessed 5 Apr 2024.
Hall NY, Le L, Majmudar I, Mihalopoulos C. Barriers to accessing opioid substitution treatment for opioid use disorder: a systematic review from the client perspective. Drug Alcohol Depend. 2021;221:108651. https://doi.org/10.1016/j.drugalcdep.2021.108651.
Article CAS PubMed Google Scholar
van de Schoot R, Sijbrandij M, Winter SD, Depaoli S, Vermunt JK. The GRoLTS-Checklist: guidelines for reporting on latent trajectory studies. Struct Equ Model Multidiscip J. 2017;24:451–67. https://doi.org/10.1080/10705511.2016.1247646.
Tacconelli E. Systematic reviews: CRD’s guidance for undertaking reviews in health care. Lancet Infect Dis. 2010;10:226. https://doi.org/10.1016/S1473-3099(10)70065-7.
Schapira L, Zheng Y, Gelber SI, et al. Trajectories of fear of cancer recurrence in young breast cancer survivors. Cancer. 2022;128:335–43. https://doi.org/10.1002/cncr.33921.
Leclair CS, Lebel S, Westmaas JL. The relationship between fear of cancer recurrence and health behaviors: a nationwide longitudinal study of cancer survivors. Health Psychol. 2019;38:596–605. https://doi.org/10.1037/hea0000754.
Brown SL, Hope-Stone L, Cherry MG. Seven-year distress trajectories in uveal melanoma survivors. Health Psychol. 2023; https://doi.org/10.1037/hea0001270.
Butow P, Müller F, Napier CE, et al. Longitudinal patterns in fear of cancer progression in patients with rare, advanced cancers undergoing comprehensive tumour genomic profiling. Psycho Oncol. 2021;30:1920–9. https://doi.org/10.1002/pon.5764.
Custers JAE, Kwakkenbos L, van der Graaf WTA, Prins JB, Gielissen MFM, Thewes B. Not as stable as we think: a descriptive study of 12 monthly assessments of fear of cancer recurrence among curatively-treated breast cancer survivors 0-5 years after surgery. Front Psychol. 2020;11 https://doi.org/10.3389/fpsyg.2020.580979.
Ng DWL, Foo C-C, Ng SSM, et al. The role of metacognition and its indirect effect through cognitive attentional syndrome on fear of cancer recurrence trajectories: a longitudinal study. Psycho Oncol. 2020;29:271–9. https://doi.org/10.1002/pon.5234.
Shim E-J, Jeong D, Lee SB, Min YH. Trajectory of fear of cancer recurrence and beliefs and rates of medication adherence in patients with breast cancer. Psycho Oncol. 2020;29:1835–41. https://doi.org/10.1002/pon.5497.
McGinty HL, Small BJ, Laronga C, Jacobsen PB. Predictors and patterns of fear of cancer recurrence in breast cancer survivors. Health Psychol. 2016;35:1–9. https://doi.org/10.1037/hea0000238.
Yang Y, Humphris G, Sun H, et al. Psychometric properties of the Chinese version Fear of Cancer Recurrence Questionnaire-7 (FCR-7). Prof Psychol Res Pract. 2019;50:376–83. https://doi.org/10.1037/pro0000257.
Thewes B, Butow P, Zachariae R, Christensen S, Simard S, Gotay C. Fear of cancer recurrence: a systematic literature review of self-report measures. Psycho Oncol. 2012;21:571–87. https://doi.org/10.1002/pon.2070.
Lasry J-CM, Margolese RG. Fear of recurrence, breast-conserving surgery, and the trade-off hypothesis. Cancer. 1992;69:2111–5. https://doi.org/10.1002/1097-0142(19920415)69:8<2111::AID-CNCR2820690817>3.0.CO;2-T.
Article CAS PubMed Google Scholar
Thewes B, Zachariae R, Christensen S, Nielsen T, Butow P. The Concerns About Recurrence Questionnaire: validation of a brief measure of fear of cancer recurrence amongst Danish and Australian breast cancer survivors. J Cancer Surviv. 2015;9:68–79. https://doi.org/10.1007/s11764-014-0383-1.
Ng DWL, Kwong A, Suen D, et al. Fear of cancer recurrence among Chinese cancer survivors: prevalence and associations with metacognition and neuroticism. Psycho Oncol. 2019;28:1243–51. https://doi.org/10.1002/pon.5073.
Shim E-J, Shin Y-W, Oh D-Y, Hahm B-J. Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatr. 2010;32:169–75. https://doi.org/10.1016/j.genhosppsych.2009.11.017.
Zhao L, Portier K, Stein K, Baker F, Smith T. Exploratory factor analysis of the Cancer Problems in Living Scale: a report from the American Cancer Society’s Studies of Cancer Survivors. J Pain Symptom Manag. 2009;37:676–86. https://doi.org/10.1016/j.jpainsymman.2008.04.011.
Thavaneswaran S, Sebastian L, Ballinger M, et al. Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancers. Med J Aust. 2018;209:354–5. https://doi.org/10.5694/mja18.00227.
Verdonck-de Leeuw IM, Jansen F, Brakenhoff RH, et al. Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: the NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank. BMC Cancer. 2019;19:765. https://doi.org/10.1186/s12885-019-5866-z.
Article CAS PubMed PubMed Central Google Scholar
Smith T, Stein KD, Mehta CC, et al. The rationale, design, and implementation of the American Cancer Society’s studies of cancer survivors. Cancer. 2007;109:1–12. https://doi.org/10.1002/cncr.22387.
Koch L, Jansen L, Brenner H, Arndt V. Fear of recurrence and disease progression in long-term (≥ 5 years) cancer survivors--a systematic review of quantitative studies. Psycho Oncol. 2013;22:1–11. https://doi.org/10.1002/pon.3022.
Mardani A, Farahani MA, Khachian A, Vaismoradi M. Fear of cancer recurrence and coping strategies among prostate cancer survivors: a qualitative study. Curr Oncol. 2023;30:6720–33. https://doi.org/10.3390/curroncol30070493.
Comments (0)